+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Blood Products Market - Global Forecast 2026-2032- Product Image
Medical Blood Products Market - Global Forecast 2026-2032- Product Image
Sale

Medical Blood Products Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6133734
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Medical Blood Products Market is projected to reach USD 17.14 Billion in 2026. It is expected to continue growing at a CAGR of 8.86%, reaching USD 28.74 Billion by 2032.

Medical Blood Products: Executive Summary

Medical blood products encompass donated blood, blood components, plasma-derived therapies, and related products used in transfusion medicine, surgery, emergency care, immunology, and chronic disease management. The field is shaped by requirements for safety, traceability, reliable cold-chain logistics, compatible supply, and clinically appropriate use. Demand patterns vary with demographics, healthcare access, trauma incidence, surgical activity, infectious-disease controls, and the availability of alternatives such as recombinant or synthetic therapies.

Safety, Resilience, and Precision Are Reshaping Blood Products

The landscape is shifting from collection-volume priorities toward integrated systems that emphasize donor health, pathogen-risk reduction, component quality, inventory visibility, and evidence-based utilization. Aging populations and complex care increase the need for dependable red-cell, platelet, and plasma availability, while stricter oversight raises expectations for testing, labeling, documentation, and adverse-event reporting. Resilience has also become a central objective, encouraging diversified collection networks, coordinated emergency planning, local capability development, and more efficient allocation of products nearing expiry.

Artificial Intelligence Strengthens Forecasting, Screening, and Quality Control

Artificial intelligence can support medical blood-product operations by improving demand forecasting, donor outreach, appointment scheduling, inventory rotation, compatibility workflows, and anomaly detection. Machine-learning tools may help identify operational bottlenecks and prioritize testing or logistics interventions, while computer vision and automated analytics can assist laboratory quality assurance. Benefits depend on representative data, clinical validation, cybersecurity, human oversight, transparent decision rules, and compliance with privacy and medical-device requirements. AI should augment-not replace-qualified transfusion specialists and established safety controls.

Regional Insights: Uneven Access Meets Common Resilience Priorities

North America generally combines advanced testing, sophisticated transfusion infrastructure, and strong regulatory systems, while addressing donor retention, aging inventories, and equitable access. Europe emphasizes harmonized safety practices, cross-border coordination, and plasma self-sufficiency, with implementation varying across countries. Asia-Pacific spans highly diverse collection capacity, healthcare access, and regulatory maturity, creating opportunities for infrastructure modernization and workforce development. Latin America continues to focus on strengthening voluntary donation, component processing, and distribution reliability. The Middle East is investing in specialized care, emergency preparedness, and regional coordination, while donor-base continuity remains important. Africa’s priorities include expanding safe collection, laboratory capacity, cold-chain reach, and access to essential blood components.

Group Insights: Coordination Shapes Standards and Supply Resilience

ASEAN members face differing levels of healthcare infrastructure and benefit from regional cooperation on standards, training, emergency transfers, and laboratory capability. BRICS economies collectively highlight the importance of domestic collection, manufacturing capacity, technology access, and equitable distribution, despite substantial internal variation. The European Union benefits from regulatory coordination and cross-border knowledge exchange while continuing to manage national differences in donation and supply systems. G7 members focus on high safety standards, innovation, preparedness, and sustainable donor engagement. GCC countries are prioritizing advanced hospital services, coordinated emergency response, and improved local supply resilience. NATO members place particular emphasis on trauma readiness, interoperable planning, and continuity of medical logistics during crises.

Country Insights: Diverse Systems Require Locally Tailored Priorities

Australia emphasizes geographically distributed collection and transport, especially for remote communities. Brazil is focused on strengthening broad donor participation, regional distribution, and component availability. Canada must balance large distances, seasonal variation, and coordinated national safety practices. China is expanding sophisticated healthcare and laboratory capabilities while managing the scale and diversity of its system. France, Germany, Italy, and Spain continue to prioritize rigorous quality systems, donor sustainability, and coordinated clinical use. India’s priorities include broader access, dependable testing, and improved collection and cold-chain infrastructure. Japan and South Korea emphasize advanced technology, aging-population needs, and operational efficiency. Mexico continues to develop donation participation and regional service capacity. Russia’s system includes substantial geographic and logistical considerations. The United Kingdom focuses on safety, donor engagement, traceability, and resilient national coordination. The United States combines advanced transfusion services with ongoing attention to donor recruitment, inventory management, equitable access, and emergency preparedness.

Action Priorities for Medical Blood-Product Leaders

Leaders should strengthen end-to-end traceability, validate contingency plans, and use interoperable data systems to connect collection, testing, storage, distribution, and clinical administration. Donor strategies should be segmented by motivation, convenience, eligibility, and retention risk, while safeguarding informed consent and donor welfare. Organizations should invest in validated automation and AI with clear governance, auditability, bias testing, cybersecurity, and clinician accountability. Clinical stewardship can reduce avoidable use through patient-blood-management programs, standardized protocols, and continuous review of transfusion outcomes. Partnerships with hospitals, public authorities, laboratories, and community organizations can improve preparedness, education, and equitable access without compromising regulatory independence.

Research Methodology: Evidence-Led Assessment of the Medical Blood-Product Ecosystem

This executive summary uses a structured qualitative assessment of medical blood products across product categories, clinical applications, operational processes, regulatory priorities, technology adoption, and geographic systems. The analysis organizes insights by the required regions, country groups, and countries, then compares recurring factors including donor participation, collection and testing capability, cold-chain reliability, clinical demand, workforce readiness, safety governance, and emergency resilience. Conclusions are limited to evidence-based structural themes and do not provide market estimates, market shares, forecasts, or company-specific assessments.

Conclusion: Safety, Access, and Resilience Define Sustainable Progress

Medical blood products remain essential to modern healthcare, but their performance depends on coordinated systems rather than isolated product availability. Sustainable progress will require reliable donors, robust testing, transparent traceability, resilient logistics, responsible technology adoption, and clinically disciplined use. Regional and national conditions differ substantially, yet the core priorities are consistent: protect patients and donors, expand equitable access, strengthen preparedness, and convert operational data into timely, accountable decisions.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Blood Products Market, by Component Type
7.1. Introduction
7.2. Cryoprecipitate
7.3. Granulocytes
7.4. Plasma
7.4.1. Fresh Frozen Plasma
7.4.2. Lyophilized Plasma
7.5. Platelets
7.5.1. Apheresis Platelets
7.5.2. Pooled Platelets
7.6. Red Blood Cells
7.6.1. Irradiated Red Blood Cells
7.6.2. Leukoreduced Red Blood Cells
7.6.3. Non-Leukoreduced Red Blood Cells
8. Medical Blood Products Market, by Donation Type
8.1. Introduction
8.2. Allogenic Donation
8.3. Autologous Donation
8.4. Directed Donation
9. Medical Blood Products Market, by Application
9.1. Introduction
9.2. Chronic Disease Management
9.3. Emergency And Trauma
9.4. Hematological Disorders
9.5. Oncology
9.6. Surgical Procedures
10. Medical Blood Products Market, by End User
10.1. Introduction
10.2. Blood Banks
10.3. Diagnostic Centers
10.4. Hospitals
10.5. Research Institutes
11. Medical Blood Products Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Medical Blood Products Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Medical Blood Products Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Asahi Kasei Corporation
15.3. B. Braun Melsungen AG
15.4. Baxter International Inc.
15.5. Becton, Dickinson and Company
15.6. Bio-Rad Laboratories, Inc.
15.7. Biotest AG
15.8. Cardinal Health, Inc.
15.9. Cerus Corporation
15.10. CSL Limited
15.11. Fresenius SE & Co. KGaA
15.12. Grifols, S.A.
15.13. Haemonetics Corporation
15.14. Kedrion Biopharma S.p.A.
15.15. Octapharma AG
15.16. Takeda Pharmaceutical Company Limited
15.17. Terumo BCT, Inc.
15.18. Terumo Corporation
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medical Blood Products Market, Years Considered for the Study
FIGURE 2. Global Medical Blood Products Market, Research Design
FIGURE 3. Global Medical Blood Products Market, Research Framework
FIGURE 4. Global Medical Blood Products Market, Data Triangulation
FIGURE 5. Global Medical Blood Products Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medical Blood Products Market Size, by Component Type, 2025 vs 2032 (%)
FIGURE 7. Global Medical Blood Products Market Size, by Component Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medical Blood Products Market Size, by Donation Type, 2025 vs 2032 (%)
FIGURE 9. Global Medical Blood Products Market Size, by Donation Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medical Blood Products Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Medical Blood Products Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medical Blood Products Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Medical Blood Products Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medical Blood Products Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Medical Blood Products Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medical Blood Products Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Medical Blood Products Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Medical Blood Products Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medical Blood Products Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medical Blood Products Market Segmentation & Coverage
TABLE 2. Global Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 4. Global Cryoprecipitate Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cryoprecipitate Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cryoprecipitate Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Granulocytes Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Granulocytes Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Granulocytes Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Fresh Frozen Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Fresh Frozen Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Fresh Frozen Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Lyophilized Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Lyophilized Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Lyophilized Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Platelets Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Platelets Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Platelets Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Apheresis Platelets Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Apheresis Platelets Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Apheresis Platelets Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Pooled Platelets Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Pooled Platelets Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Pooled Platelets Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Red Blood Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Red Blood Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Red Blood Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Irradiated Red Blood Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Irradiated Red Blood Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Irradiated Red Blood Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Leukoreduced Red Blood Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Leukoreduced Red Blood Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Leukoreduced Red Blood Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Non-Leukoreduced Red Blood Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Non-Leukoreduced Red Blood Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Non-Leukoreduced Red Blood Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 41. Global Allogenic Donation Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Allogenic Donation Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Allogenic Donation Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Autologous Donation Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Autologous Donation Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Autologous Donation Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Directed Donation Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Directed Donation Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Directed Donation Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 51. Global Chronic Disease Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Chronic Disease Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Chronic Disease Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Emergency And Trauma Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Emergency And Trauma Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Emergency And Trauma Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Hematological Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Hematological Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Hematological Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Surgical Procedures Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Surgical Procedures Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Surgical Procedures Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. Global Blood Banks Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Blood Banks Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Blood Banks Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Medical Blood Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Medical Blood Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. North America Medical Blood Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. North America Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 90. North America Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 91. North America Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 92. North America Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 93. North America Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 94. North America Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. North America Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Latin America Medical Blood Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Latin America Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 98. Latin America Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 99. Latin America Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 100. Latin America Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 101. Latin America Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 102. Latin America Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Latin America Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Europe Medical Blood Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Europe Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 106. Europe Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 107. Europe Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 108. Europe Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 109. Europe Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 110. Europe Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. Europe Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Middle East Medical Blood Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Middle East Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 114. Middle East Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 115. Middle East Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 116. Middle East Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 117. Middle East Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 118. Middle East Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. Middle East Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. Africa Medical Blood Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Africa Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 122. Africa Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 123. Africa Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 124. Africa Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 125. Africa Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 126. Africa Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. Africa Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Global Medical Blood Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. ASEAN Medical Blood Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. ASEAN Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 131. ASEAN Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 132. ASEAN Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 133. ASEAN Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 134. ASEAN Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 135. ASEAN Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. ASEAN Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. GCC Medical Blood Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. GCC Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 139. GCC Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 140. GCC Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 141. GCC Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 142. GCC Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 143. GCC Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. GCC Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. European Union Medical Blood Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. European Union Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 147. European Union Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 148. European Union Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 149. European Union Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 150. European Union Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 151. European Union Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. European Union Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. BRICS Medical Blood Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. BRICS Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 155. BRICS Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 156. BRICS Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 157. BRICS Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 158. BRICS Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 159. BRICS Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. BRICS Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. G7 Medical Blood Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. G7 Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 163. G7 Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 164. G7 Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 165. G7 Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 166. G7 Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 167. G7 Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. G7 Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. NATO Medical Blood Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. NATO Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 171. NATO Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 172. NATO Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 173. NATO Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 174. NATO Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 175. NATO Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. NATO Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Global Medical Blood Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. United States Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 179. United States Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 180. United States Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 181. United States Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 182. United States Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 183. United States Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 184. United States Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. United States Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Canada Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 187. Canada Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 188. Canada Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 189. Canada Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 190. Canada Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 191. Canada Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 192. Canada Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. Canada Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Mexico Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 195. Mexico Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 196. Mexico Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 197. Mexico Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 198. Mexico Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 199. Mexico Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 200. Mexico Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Mexico Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Brazil Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 203. Brazil Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 204. Brazil Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 205. Brazil Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 206. Brazil Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 207. Brazil Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 208. Brazil Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Brazil Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. United Kingdom Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 211. United Kingdom Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 212. United Kingdom Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 213. United Kingdom Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 214. United Kingdom Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 215. United Kingdom Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 216. United Kingdom Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. United Kingdom Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Germany Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 219. Germany Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 220. Germany Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 221. Germany Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 222. Germany Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 223. Germany Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 224. Germany Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. Germany Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. France Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 227. France Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 228. France Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 229. France Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 230. France Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 231. France Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 232. France Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. France Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Russia Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 235. Russia Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 236. Russia Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 237. Russia Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 238. Russia Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 239. Russia Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 240. Russia Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. Russia Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Italy Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 243. Italy Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 244. Italy Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 245. Italy Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 246. Italy Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 247. Italy Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 248. Italy Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. Italy Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Spain Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 251. Spain Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 252. Spain Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 253. Spain Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 254. Spain Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 255. Spain Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 256. Spain Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 257. Spain Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. China Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 259. China Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 260. China Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 261. China Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 262. China Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 263. China Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 264. China Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. China Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. India Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 267. India Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 268. India Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 269. India Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 270. India Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 271. India Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 272. India Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. India Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Japan Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 275. Japan Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 276. Japan Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 277. Japan Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 278. Japan Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 279. Japan Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 280. Japan Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. Japan Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. Australia Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 283. Australia Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 284. Australia Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 285. Australia Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 286. Australia Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 287. Australia Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 288. Australia Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. Australia Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. South Korea Medical Blood Products Market Size, 2017-2032 (USD Million)
TABLE 291. South Korea Medical Blood Products Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 292. South Korea Medical Blood Products Market Size, by Plasma, 2017-2032 (USD Million)
TABLE 293. South Korea Medical Blood Products Market Size, by Platelets, 2017-2032 (USD Million)
TABLE 294. South Korea Medical Blood Products Market Size, by Red Blood Cells, 2017-2032 (USD Million)
TABLE 295. South Korea Medical Blood Products Market Size, by Donation Type, 2017-2032 (USD Million)
TABLE 296. South Korea Medical Blood Products Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. South Korea Medical Blood Products Market Size, by End User, 2017-2032 (USD Million)
TABLE 298. Global Medical Blood Products Market Share, by Key Player, 2025
TABLE 299. Global Medical Blood Products Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biotest AG
  • Cardinal Health, Inc.
  • Cerus Corporation
  • CSL Limited
  • Fresenius SE & Co. KGaA
  • Grifols, S.A.
  • Haemonetics Corporation
  • Kedrion Biopharma S.p.A.
  • Octapharma AG
  • Takeda Pharmaceutical Company Limited
  • Terumo BCT, Inc.
  • Terumo Corporation

Related Topics

Related Reports

Blood Banking & Blood Products Market - Global Forecast 2026-2032 - Product Image

Blood Banking & Blood Products Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Blood Banking and Blood Products - Global Strategic Business Report - Product Image

Blood Banking and Blood Products - Global Strategic Business Report

  • Report
  • 548 Pages
  • Global
From
Synthetic Blood Substitutes and Blood Products Market Report 2026 - Product Image

Synthetic Blood Substitutes and Blood Products Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Blood Product Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Blood Product Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 182 Pages
  • Global
From
2025 Global Forecast for Synthetic Blood Substitutes and Blood Product Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Synthetic Blood Substitutes and Blood Product Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.